0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Communications |

Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile

Giuseppe Nunnari, MD; Luciano Nigro, MD; Filippo Palermo, ScD; Massimo Attanasio, PhD; Annemarie Berger, MD; Hans W. Doerr, MD; Roger J. Pomerantz, MD; and Bruno Cacopardo, MD
[+] Article and Author Information

From University of Catania, Catania, Italy; Thomas Jefferson University, Philadelphia, Pennsylvania; University of Palermo, Palermo, Italy; and Johann Wolfgang Goethe University, Frankfurt/Main, Germany.


Acknowledgments: The authors thank the patients from the University of Catania clinics. They also thank Brenda O. Gordon and Rita Victor at the Center for Human Virology and Biodefense, Thomas Jefferson University, for excellent secretarial assistance and Drs. Carlo Vancheri and Valerio Tomaselli from the Chest Disease Unit of the Department of Internal Medicine and Medical Specialties at the University of Catania for providing some of the laboratory reagents.

Grant Support: By academic funds from the Institute of Infectious Diseases, University of Catania; the Center for Human Virology and Biodefense, Thomas Jefferson University; and the Institute of Medical Virology, Johann Wolfgang Goethe University.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Giuseppe Nunnari, MD, Jefferson Alumni Hall, Thomas Jefferson University, 1020 Locust Street, Suite 329, Philadelphia, PA 19107; e-mail, gnunnari@hotmail.com.

Current Author Addresses: Drs. Nunnari and Pomerantz: Jefferson Alumni Hall, Thomas Jefferson University, 1020 Locust Street, Suite 329, Philadelphia, PA 19107.

Drs. Nigro, Palermo, and Cacopardo: Unit of Infectious Diseases, University of Catania, Via Passo Gravina 185, 95125 Catania, Italy.

Drs. Berger and Doerr: Institute fur Medizinische Virologie, Paul-Ehrlich Strasse 40, 60596 Frankfurt, Germany.

Dr. Attanasio: Dipartimento dei Metodi Quantitativi per le Scienze Umane, University of Palermo, Viale delle Scienze, 90128 Palermo, Italy.

Author Contributions: Conception and design: G. Nunnari, L. Nigro, H.W. Doerr, R.J. Pomerantz, B. Cacopardo.

Analysis and interpretation of the data: G. Nunnari, L Nigro, F. Palermo, R.J. Pomerantz, B. Cacopardo.

Drafting of the article: G. Nunnari, R.J. Pomerantz, B. Cacopardo.

Critical revision of the article for important intellectual content: G. Nunnari, R.J. Pomerantz, B. Cacopardo.

Final approval of the article: G. Nunnari, R.J. Pomerantz, B. Cacopardo.

Statistical expertise: F. Palermo, M. Attanasio.

Obtaining of funding: B. Cacopardo.

Administrative, technical, or logistic support: A. Berger, H.W. Doerr.

Collection and assembly of data: G. Nunnari, L. Nigro, F. Palermo, A. Berger, H.W. Doerr, B. Cacopardo.


Ann Intern Med. 2003;139(1):26-30. doi:10.7326/0003-4819-139-1-200307010-00009
Text Size: A A A

Background: Progression to AIDS is slower in persons infected with both HIV-1 and GB virus C (GBV-C), also known as hepatitis G virus.

Objective: To compare clinical, virologic, and immunologic variables in HIV-1seropositive patients with and without GBV-C co-infection.

Design: Subanalysis of a prospective cohort study.

Setting: Institute of Infectious Diseases, University of Catania, Catania, Italy.

Patients: 80 asymptomatic HIV-1seropositive patients.

Measurements: GBV-C RNA level; plasma HIV-1 viral load; CD4+ cell counts; and serum levels of interleukin (IL)-2, IL-4, IL-10, and IL-12.

Results: At the start of the study, plasma GBV-C RNA was detected in 17 patients (21%). During follow-up, IL-2 and IL-12 levels decreased significantly (P = 0.005 and P = 0.01, respectively) and IL-4 and IL-10 levels increased significantly (P = 0.01 and P = 0.004, respectively) in the GBV-Cnegative group but did not change substantially in the GBV-Cpositive group. Each measured variable differed significantly between GBV-Cpositive and GBV-Cnegative groups during follow-up (P < 0.001 for IL-12, IL-4, and IL-10; P = 0.002 for IL-2).

Conclusion: GB virus C may immunologically interfere with progression of HIV-1 infection to AIDS by maintaining an intact T-helper 1 cytokine profile.

Figures

Grahic Jump Location
Figure.
Cross-sectional averages of interleukin (IL) levels, CD4+ cell counts, and HIV-1 RNA levels in GB virus C (GBV-C)-positive and GBV-C–negative patients during 8 years of follow-up.PP

Comparison of GBV-C–positive and GBV-C–negative patients was based on each immunologic and virologic variable examined during follow-up (analysis of variance for repeated measures). < 0.001 for all variables except IL-2, for which = 0.002.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Hepatitis G Virus Co-Infection Slows Progression from HIV Infection to AIDS: The Potential Role of Cytokines

The summary below is from the full report titled “Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile.” It is in the 1 July 2003 issue of Annals of Internal Medicine (volume 139, pages 26-30). The authors are G. Nunnari, L. Nigro, F. Palermo, M. Attanasio, A. Berger, H.W. Doerr, R.J. Pomerantz, and B. Cacopardo.

Read More...

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)